For the quarter ending 2025-06-30, KNW had -$2,938,252 decrease in cash & cash equivalents over the period. -$4,488,875 in free cash flow.
| Cash Flow | 2025-06-30 |
|---|---|
| Stock based compensation - stock option grants | 1,144,384 |
| Net loss | 9,773,145 |
| Amortization of operating lease right-of-use asset | 84,401 |
| Issuance of common stock for services | 176,000 |
| Interest expense for default of convertible notes | 748,600 |
| Operating lease right-of-use liability | -77,573 |
| Accounts payable - trade and accrued expenses | 542,937 |
| Depreciation and amortization | 24,208 |
| Amortization of debt issuance costs | 1,040,872 |
| Interest expense for repricing of warrants | 233,644 |
| Other long-term assets | 125,000 |
| Loss on debt extinguishment | 728,298 |
| Interest expense for extension of notes and warrants | 513,499 |
| Net cash used in operating activities | -4,488,875 |
| Purchase of research and development equipment | 0 |
| Net cash used in investing activities | 0 |
| Repayment of note payable | 480,000 |
| Proceeds from at the market common stock offering | 1,284,623 |
| Proceeds from original issuance notes | 246,000 |
| Proceeds from issuance of common stock offering, net | 300,000 |
| Proceeds from debt offering | 200,000 |
| Payments for debt offering | 0 |
| Net cash provided by financing activities | 1,550,623 |
| Net decrease in cash and cash equivalents | -2,938,252 |
KNOW LABS, INC. (KNW)
KNOW LABS, INC. (KNW)